G4919

Goserelinacetat

≥99% (HPLC), white, powder

• Synonym(e): [D-Ser(tBu)⁶,Azagly¹⁰]-LHRH -acetat (Salz)
• Empirische Formel (Hill-System): C₅₉H₈₄N₁₈O₁₄
• CAS-Nummer: 145781-92-6
• Molekulargewicht: 1269.41
• MDL-Nummer: MFCD01747329
• UNSPSC-Code: 51111800
• PubChem Substanz-ID: 329799933
• NACRES: NA.32

Eigenschaften

• Qualitätsniveau: 200
• Assay: ≥99% (HPLC)
• Form: powder
• Farbe: white
• Löslichkeit: H₂O: 20 mg/mL, clear, colorless
• UniProt-Hinterlegungsnummer: P55248; P01148; P07490; P13562; P30968; P30969; Q01776
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6C(=O)NNC(N)=O
• InChI: 1S/C59H84N18O14.C2H4O2/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38;1-2(3)4/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90);1H3,(H,3,4)/t38-,39-,40-,41-,42-,43-,44-,45+,46-;/m0./s1
• InChIKey: IKDXDQDKCZPQSZ-JHYYTBFNSA-N
• Angaben zum Gen: human ... GNRH1(2796) , GNRHR(2798) ; mouse ... GNRH1(14714) , GNRHR(14715) ; rat ... GNRH1(25194) , GNRHR(81668)

Beschreibung

Amino Acid Sequence

Glp-His-Trp-Ser-Tyr-Ser(tBu)-Leu-Arg-Pro-azaGly-NH2

Allgemeine Beschreibung

Goserelin acetate is a synthetic decapaptide, which is a potent analog of LHRH (luteinizing hormone releasing hormone).

Goserelin is used to guard ovary during breast-cancer adjuvant chemotherapy.

Biochem./physiol. Wirkung

Goserelin acetate peptide results in significant inhibition of gonadotropin release and suppresses steroidogenesis in ovaries and testis. Thus, it leads to a reduction of testosterone to castration levels and estrogen to postmenopausal levels. Therefore, this peptide is used for reducing testosterone levels in patients with locally advanced prostate cancer.

Goserelin ist ein synthetisches Analogon des LHRH (luteinisierendes Hormon Releasing-Hormon) und ein LHRH-Agonist. Es wird bei der Therapie von Prostatakrebs und Brustkrebs, sowie der Behandlung von Endometriose angewendet.

Sicherheitshinweise

• Piktogramme: GHS08
• Signalwort: Danger
• H-Sätze: H360
• P-Sätze: P201 - P202 - P280 - P308 + P313 - P405 - P501
• Gefahreneinstufungen: Repr. 1B
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)